Ehime University et al. receive research grant for development of malaria vaccines
Category: Announcements
Created: Tuesday, 07 April 2020
The Proteo-Science Center (PROS), Ehime University et al. research group, which is the strategic technical partner of our company, has received a research grant totaling approximately 600 million yen for research to develop transmission-blocking vaccines for malaria elimination from Global Health Innovative Technology Fund (GHIT Fund).
Up to now we have supplied wheat germ extract to support malaria research through wheat germ cell-free protein expression system and it is our hope this malaria vaccine development will be one more step of progress in the battle to malaria elimination.
